select trial semaglutide cardiovascular outcomes without diabetes 2023 The - A New Era in Obesity and Care U.S. Eligibility and Preventable Cardiovascular,

Post-transplant diabetes mellitus is associated with worse liver allograft outcomes, including an increased risk of rejection and late-onset hepatic artery thrombosis

Cardiovascular stimulation warrants attention

Peptides aren't a shortcut - they're an option for providers to help certain people who've already done solid foundational work but perhaps not progressed

Several studies suggest that similar to lipids, reductions in food intake via intestinal protein in rodents are due to CCK release and subsequent activation of VANs, as (1) intestinal protein infusion increases CCK in rodents and humans 188,189

In addition, facial areas can also benefit from refinement

GIP (Glucose-Dependent Insulinotropic Polypeptide) GIP is the second major incretin hormone, secreted by intestinal K cells, with more complex metabolic effects than GLP-1: Glucose-dependent insulin secretion (similar to GLP-1) Direct effects on adipose tissue , including lipid storage and adipocyte biology Bone-metabolism effects via osteoblasts and osteoclasts Central nervous system effects modulating appetite and food reward GIP's role in metabolic research has evolved